OBJECTIVE	The objective of our study was to define the interaction between either unfractionated heparin ( UFH ) or a low molecular weight heparin , reviparin ( REV ) , and the pharmacodynamic profile of the GPIIb/IIIa-antagonists abciximab ( ABC ) or tirofiban ( T ) .\